José Federico
Díaz González
Catedrático de Universidad
Hospital Universitario Reina Sofia
Córdoba, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (9)
2024
-
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
European Journal of Clinical Investigation, Vol. 54, Núm. 2
2021
-
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
Scientific Reports, Vol. 11, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: Data from the BIOBADASER III register
Arthritis Research and Therapy, Vol. 22, Núm. 1
2019
-
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry
Rheumatology International, Vol. 39, Núm. 3, pp. 509-515
2015
-
Documento de posicionamiento de la Sociedad Española de Reumatología sobre fármacos biosimilares
Reumatologia Clinica, Vol. 11, Núm. 5, pp. 269-278
-
Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]
Seminars in Arthritis and Rheumatism
2011
-
Eficacia y seguridad de abatacept en pacientes con artritis reumatoide sin tratamiento biológico previo
Reumatologia Clinica
-
No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis
Clinical and Experimental Rheumatology